Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced

Maria Obrero1, David V Yu, David J Shapiro

  • 1Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA.

Insights

Tamoxifen (TAM) and its metabolite 4-hydroxytamoxifen (OHT) induce cancer cell death via estrogen receptor (ER)-dependent and ER-independent pathways. This novel finding reveals new therapeutic strategies for cancer treatment.

Area of Science:

  • Cell Biology
  • Pharmacology
  • Cancer Research

Background:

  • Tamoxifen (TAM) is a widely used cancer therapeutic agent, primarily functioning by competing with estrogens for estrogen receptor (ER) binding.
  • The precise mechanisms underlying TAM's therapeutic efficacy, particularly its role in programmed cell death, are not fully elucidated.

Purpose of the Study:

  • To investigate the distinct pathways through which TAM and its active metabolite, 4-hydroxytamoxifen (OHT), induce programmed cell death.
  • To differentiate between ER-dependent and ER-independent mechanisms of cell death triggered by TAM and OHT.

Main Methods:

  • Utilized various concentrations of TAM and OHT in both ER-positive and ER-negative cancer cell lines.
  • Employed ER ligands (17beta-estradiol, raloxifene, ICI 182,780) and a p38 inhibitor (SB203580) to dissect signaling pathways.
  • Assessed hallmarks of apoptosis, including Bax translocation, cytochrome c release, poly(ADP-ribose) polymerase cleavage, and DNA laddering.

Main Results:

  • TAM and OHT induce programmed cell death through both ER-dependent and ER-independent pathways.
  • The ER-independent pathway is activated at higher concentrations (10-20 micromolar) and occurs in ER-negative cells.
  • The ER-dependent pathway, triggered by submicromolar concentrations, involves stress kinase pathways and diverges from classical caspase-dependent apoptosis.

Conclusions:

  • Tamoxifen and 4-hydroxytamoxifen possess novel activities beyond ER antagonism, including the direct induction of programmed cell death.
  • Understanding these distinct cell death pathways offers potential for developing more effective and targeted cancer therapies.
  • The ER-dependent cell death pathway initiated by OHT appears to bypass key caspase activation steps, representing a unique mode of apoptosis induction.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...